Cas:70624-30-5 2-(5-methylthiophen-2-yl)acetic acid manufacturer & supplier

We serve Chemical Name:2-(5-methylthiophen-2-yl)acetic acid CAS:70624-30-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

2-(5-methylthiophen-2-yl)acetic acid

Chemical Name:2-(5-methylthiophen-2-yl)acetic acid
CAS.NO:70624-30-5
Synonyms:5-methyl-2-carboxymethylthiophene;5-methyl-thienylacetic acid;(5-methylthiophen-2-yl)acetic acid;(5-methylthien-2-yl)acetic acid;5-methyl-2-thiopheneacetic acid;(5-methyl-[2]thienyl)-acetic acid
Molecular Formula:C7H8O2S
Molecular Weight:156.20200
HS Code:2934999090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:65.54000
Exact Mass:156.02500
LogP:1.68360

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 5-methyl-2-carboxymethylthiophene chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,(5-methyl-[2]thienyl)-acetic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(5-methyl-[2]thienyl)-acetic acid Use and application,5-methyl-thienylacetic acid technical grade,usp/ep/jp grade.


Related News: But Sanofi’s rival CD38 antibody Sarclisa may soon be able to challenge Darzalex in the same front-line, transplant-ineligible population with the help of a more powerful backbone. 2-(5-methylthiophen-2-yl)acetic acid manufacturer The memo denies the company made false statements to the FDA. In their complaint, employees said they were broadly concerned that quality control documents the FDA requires companies to maintain had been rewritten or fabricated. The employees did not specify whether these materials had been shown to the FDA. 2-(5-methylthiophen-2-yl)acetic acid supplier The vaccine also proved safe during the two-year trial, in which eleven doses were administered to randomly chosen patients with mild dementia. People who received the vaccine, known as AADvac1, experienced about the same numbers of side effects and adverse events as those who were given a placebo. 2-(5-methylthiophen-2-yl)acetic acid vendor The third-to-market BTK inhibitor is also looking to report top-line results from a front-line trial later this year. Imbruvica could feel more pressure if that study also turns out successful. 2-(5-methylthiophen-2-yl)acetic acid factory The third-to-market BTK inhibitor is also looking to report top-line results from a front-line trial later this year. Imbruvica could feel more pressure if that study also turns out successful.